ArticleCureus2025
Assessment of Medication Adherence to Anti-tuberculosis Treatment Among Patients With Tuberculosis at a Tertiary Care Hospital in South Gujarat, India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Tuberculosis (TB) remains a major public health challenge, especially in developing countries like India. A successful TB treatment relies heavily on good medication adherence, which helps to prevent complications such as drug resistance and poor treatment outcomes. Multiple factors influence medication adherence, including socioeconomic, patient-related, and therapy-related aspects. Objectives This study aims to assess the level of medication adherence and factors affecting medication adherence in TB patients during treatment. Methodology A cross-sectional observational study was conducted among 223 TB patients (≥18 years) who had received more than two months of anti-TB treatment in a tertiary care hospital. Medication adherence was assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8). Data were analysed based on demographic and clinical variables using IBM SPSS Statistics for Windows, V. 30.0 (IBM Corp., Armonk, NY, USA). Results Among 223 patients, 126 (56.5%) were male and 97 (43.5%) were female with a mean age of 35.08 ± 13.28 years. Using MMAS-8 to analyse medication adherence levels, 150 (67%) patients showed high medication adherence, 41 (18%) medium, and 32 (15%) low. High medication adherence was more prevalent among 70 (72.16%) females as compared to 80 (63.49%) males. Medication adherence was similar between 92 drug-sensitive TB (67.6% high medication adherence) and 58 drug-resistant TB (66.7% high medication adherence) cases. The most common factors affecting medication adherence were difficulty in procurement of medicines, lack of family support, and misunderstanding of treatment schedules. The most frequently reported adverse drug reaction was gastrointestinal upset (60, 46.9%), followed by neuropathy (22, 17.2%) and arthralgia (15, 11.7%). Conclusion The study showed good medication adherence among TB patients, supported by programmatic measures. Maintaining and enhancing medication adherence still requires addressing financial obstacles, enhancing medication availability, and monitoring and managing adverse reactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.